Hibernian Investment Managers

Hibernian Investment Managers (HIM) was a prominent Dublin-based asset management firm that served as the investment arm of the Hibernian Group, which is now part of Aviva plc. During the early 2000s, the firm was a significant institutional player in the European life sciences sector, notably managing specialized vehicles such as the Hibernian Biotechnology Fund. While not a drug development company itself, HIM provided critical capital and institutional analysis for the biotech industry, holding major stakes in companies like Elan Corporation. Following the acquisition of the Hibernian Group by Aviva, the entity was integrated into Aviva Investors Ireland, marking the end of its independent operation under the Hibernian brand.